HARRISBURG, Pa., Feb. 6 (UPI) -- Although only 25 percent of eligible African-American adolescent girls have received the HPV vaccine, a U.S. survey indicates more are open to the vaccine.
BALTIMORE, Nov. 13 (UPI) -- A group of U.S. researchers suggests it is premature for states to mandate the human papillomavirus vaccine as a condition for school attendance.
ATLANTA, Oct. 10 (UPI) -- One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said.
WASHINGTON, March 20 (UPI) -- Pharmaceutical manufacturer Merck & Co. Inc. said the U.S. Food and Drug Administration will consider expanding the use of its cervical cancer vaccine.
PROVIDENCE, R.I., Nov. 28 (UPI) -- A U.S. study suggested that, in addition to girls and young women, men and boys should be given the human papillomavirus vaccine.
BETHESDA, Md., Aug. 15 (UPI) -- For women with human papillomavirus infection, the HPV-16/18 vaccine should not be used to treat the infection, a U.S. researcher advised.
LOS ANGELES, April 17 (UPI) -- British-based global drug giant GlaxoSmithKline said Tuesday its human papillomavirus vaccine Cervarix shows 100 percent efficacy against the deadliest HPV.
ATLANTA, Feb. 28 (UPI) -- One in four U.S. females between the ages of 14 and 59 years may have the sexually transmitted infection human papillomavirus, or HPV.
BOSTON, Aug. 22 (UPI) -- The new vaccine against human papillomavirus or HPV promises to save lives, but it won't make Pap tests unnecessary, say Boston researchers.
SALVADOR DA BAHIA, Brazil, June 14 (UPI) -- A $7 million grant from Bill Gates' foundation will help speed efforts to launch a vaccine that could prevent most cervical cancer, officials announced in Brazil.
